Advertisement

Clarithromycin Treatment of Helicobacter pylori and Chlamydia pneumoniae Infections Decreases Fibrinogen Plasma Level in Patients with Ischemic Heart Disease

  • L. Allegra
  • R. Cosentini
  • P. Tarsia

Abstract

Recent data suggest that active inflammation and/or infection in the coronary arteries may play a role in ischemic heart disease (IHD) [1, 2]. The infectious theory has been suggested by epidemiological, serological, immunohistochemical and in situ hybridization studies, which indicated a possible etiologic role of some viruses and bacteria in the development of atherosclerotic lesions [3–5]. Among the micro-organisms potentially implicated, Chlamydia pneumoniae is the most extensively studied in the literature [6–9].

Keywords

Ischemic Heart Disease Pylorus Infection Fibrinogen Level Ischemic Heart Disease Patient Chronic Coronary Heart Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nieminen MS, Mattila K, Valtonen V (1993) Infection and inflammation as a risk factor for myocardial infarction. Eur Heart J 14[Suppl K]: 12–16PubMedGoogle Scholar
  2. 2.
    Alexander RW (1994) Inflammation and coronary artery disease. N Engl J Med 331: 468–469PubMedCrossRefGoogle Scholar
  3. 3.
    Beneditt EP, Barret T, McDougall JK (1983) Viruses and etiology of atherosclerosis. Proc Natl Acad Sci USA 80: 6386–6389CrossRefGoogle Scholar
  4. 4.
    Pesonen E, Siitonen O (1981) Acute myocardial infarction precipitated by infectious diseases. Am Heart J 101: 512–513PubMedCrossRefGoogle Scholar
  5. 5.
    Spodick DH, Flessas AP, Johnson MM (1984) Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol 53: 481–482PubMedCrossRefGoogle Scholar
  6. 6.
    Saikku P (1993) Chlamydia pneumoniae as a risk factor in acute myocardial infarction. Eur Heart J 14[Suppl K]: 62–65PubMedGoogle Scholar
  7. 7.
    Saikku P, Leinonen M, Mattila K et al (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii: 983–986CrossRefGoogle Scholar
  8. 8.
    Shor A, Kuo C-C, Patton DL (1992) Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 82: 158–161PubMedGoogle Scholar
  9. 9.
    Kuo C-C, Shor A, Campbell LA et al (1993) Demonstration of Chlamydia pneumoniaein atherosclerotic lesions of coronary arteries. J Infect Dis 167: 845–849CrossRefGoogle Scholar
  10. 10.
    Mendall MA, Goggin PM, Molineaux N et al (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71: 437–439PubMedCrossRefGoogle Scholar
  11. 11.
    Aceti A, Mazzacurati G, Amendola MA et al (1996) H. pylori and C. pneumoniae infections may account for most acute coronary syndrome. BMJ 313: 428–429PubMedCrossRefGoogle Scholar
  12. 12.
    Morgando A, Sanseverino P, Perotto C et al (1995) Helicobacter pylori seropositivity in myocardial infarction. Lancet 345: 1380 (letter)PubMedGoogle Scholar
  13. 13.
    Patel P, Carrington D, Strachan DP et al (1994) Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 343: 1634–1635PubMedCrossRefGoogle Scholar
  14. 14.
    Wald NJ, Law MR, Morris JK et al (1997) Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ 315: 1199–1201PubMedCrossRefGoogle Scholar
  15. 15.
    Gupta S, Leatham EW, Carrington D et al (1997) Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96: 404–407PubMedGoogle Scholar
  16. 16.
    Gurfinkel E, Bozovich G, Daroca A et al (1997) Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet 350: 404–407PubMedCrossRefGoogle Scholar
  17. 17.
    Agen C, Danesi R, Blandizzi C et al (1993) Macrolide antibiotics as antiinflammatory agents: roxithromycin in an unexpected role. Agents Actions 38:(1–2)85–90PubMedCrossRefGoogle Scholar
  18. 18.
    Liuzzo G, Biasucci LM, Gallimore JR et al (1994) The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331: 417–424PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia, Milano 1999

Authors and Affiliations

  • L. Allegra
  • R. Cosentini
  • P. Tarsia

There are no affiliations available

Personalised recommendations